Abstract:Primary large cell neuroendocrine carcinomas (LCNEC) of the urinary bladder are rare. Reported herein is a case of a primary, pure LCNEC occurring in a man. The patient was a 32-year-old man who presented with hematuria of 1 week's duration. On cystoscopic examination, a solitary mass measuring 3 cm in diameter was detected protruding from the anterosuperior wall of the urinary bladder. Two months after the primary transurethral resection, significant regrowth of the remnant mass was noted on CT, and the patie… Show more
“…The most widely accepted view of the histogenesis seems that large cell neuroendocrine carcinoma of the bladder originates in a pluripotential stem cell that can differentiate into various cell types. [1][2][3]5,7 It is interesting to note that the urothelial carcinoma and large cell neuroendocrine carcinoma in the current case were entirely independent in terms of time of occurrence, localization, morphology and immunoprofile. Table I summarizes 14 reported cases of large cell neuroendocrine carcinoma of the bladder in the literature and the current case.…”
Section: Discussionmentioning
confidence: 99%
“…Of these, 11 were stage III or IV, resulting in poor prognoses despite cystectomy, chemotherapy or radiotherapy. 1,2,4,[7][8][9] The only long-term survivors were patients in whom the tumor was organ confined and successfully removed by cystectomy. To establish effective therapeutic strategies, earlier detection of this tumor will be the issue of greatest concern.…”
“…The most widely accepted view of the histogenesis seems that large cell neuroendocrine carcinoma of the bladder originates in a pluripotential stem cell that can differentiate into various cell types. [1][2][3]5,7 It is interesting to note that the urothelial carcinoma and large cell neuroendocrine carcinoma in the current case were entirely independent in terms of time of occurrence, localization, morphology and immunoprofile. Table I summarizes 14 reported cases of large cell neuroendocrine carcinoma of the bladder in the literature and the current case.…”
Section: Discussionmentioning
confidence: 99%
“…Of these, 11 were stage III or IV, resulting in poor prognoses despite cystectomy, chemotherapy or radiotherapy. 1,2,4,[7][8][9] The only long-term survivors were patients in whom the tumor was organ confined and successfully removed by cystectomy. To establish effective therapeutic strategies, earlier detection of this tumor will be the issue of greatest concern.…”
“…Lee et al [10] report a case of LCCB in a 32-year-old man treated with partial cystectomy and adjuvant chemotherapy. Metastasis at lung and liver was present 12 months after the diagnosis.…”
Section: Discussionmentioning
confidence: 99%
“…Primary SCCB is a rare disease that accounts for less than 0.7% of all bladder cancers [29,30]. Primary LCCB is an even rarer disease first described in 1986 [4] and with 17 more cases reported since then [5,6,7,8,9,10,11,12,13,14,15,16]. …”
Section: Discussionmentioning
confidence: 99%
“…Large cell carcinoma of the urinary bladder (LCCB) was first reported in 1986 [4] and since then 17 more cases have been described on the literature [5,6,7,8,9,10,11,12,13,14,15,16]. Because of the relative rarity of these tumors there is no standard approach for managing SCCB [17] or LCCB [13].…”
Introduction: Neuroendocrine carcinomas of the urinary bladder are relatively rare, accounting for less than 1% of all bladder carcinomas. These tumors can be divided into the more indolent typical or atypical carcinoid tumors and the aggressive small cell and large cell neuroendocrine carcinomas. Objective: To report 2 clinical cases of large cell neuroendocrine carcinoma of the bladder (LCCB) and to review the epidemiology, prognosis, and current treatment algorithms for patients with bladder small and large cell neuroendocrine carcinomas. Results: In both cases hematuria was the presenting symptom. One patient was submitted to partial cystectomy and the other to trans-urethral resection of the bladder tumor. The former patient died on the third month postoperatively. The latter patient had extensive liver metastasis at the time of diagnosis and died from acute liver failure on the 14th postoperative day. In review LCCB is associated with a more aggressive behavior and poorer prognosis than transitional cell bladder carcinoma. No standard approach exists. Surgery (transurethral ressection, partial cystectomy, radical cystectomy), chemotherapy and radiotherapy are current treatment modalities. Conclusion: LCCB is an aggressive tumor which usually presents itself in an advanced stage. Neoadjuvant chemotherapy with platinum regimen plus aggressive surgical approach should be the treatment of choice.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.